Update and review of central retinal vein occlusion

Current Opinion in Ophthalmology

Volumn 22, Issue 3, 2011, Pages 159-165

  London, Nikolas Js ^a,b   Brown, Gary ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

anti vascular endothelial growth factor; ischemic; macular edema; nonischemic; vascular

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CORTICOSTEROID; DEXAMETHASONE; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN INHIBITOR;

ANEMIA; ARTICLE; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; ELECTRORETINOGRAPHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; HYPERTENSION RETINOPATHY; HYPERVISCOSITY SYNDROME; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; MULTICENTER STUDY (TOPIC); OCULAR ISCHEMIC SYNDROME; OPTICAL COHERENCE TOMOGRAPHY; PANRETINAL LASER PHOTOCOAGULATION; PARS PLANA VITRECTOMY; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIAL OPTIC NEUROTOMY; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; SLIT LAMP; SUSTAINED DRUG RELEASE; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

ANGIOGENESIS INHIBITORS; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; RETINAL VEIN OCCLUSION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955058357     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283459737     Document Type: Article

References (41)

1. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117:429-441. (Pubitemid 24115701)
2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114:1243-1247. (Pubitemid 26338856)
3. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98:133-141; discussion 41-43.
4. Gutman FA. Evaluation of a patient with central retinal vein occlusion. Ophthalmology 1983; 90:481-483. (Pubitemid 13059776)
5. David R, Zangwill L, Badarna M, Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 1988; 197:69-74.
6. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993; 37:393-417. (Pubitemid 23144010)
7. Gottlieb JL, Blice JP, Mestichelli B, et al. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 1998; 116:577-579. (Pubitemid 28414570)
8. Lahey JM, Tunc M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002; 109:126-131. (Pubitemid 34027435)
9. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1996; 114:545-554.
10. Lindblom B. Open angle glaucoma and noncentral retinal vein occlusion - the chicken or the egg? Acta Ophthalmol Scand 1998; 76:329-333. (Pubitemid 28327590)
11. Arend O, Remky A, Jung F, et al. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology 1996; 103: 80-86. (Pubitemid 26046163)
12. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983; 90:458-474. (Pubitemid 13059774)
13. Hayreh SS, Klugman MR, Beri M, et al. Differentiation of ischemic from nonischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 1990; 228:201-217. (Pubitemid 20150302)
14. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995; 102:1434-1444.
15. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993; 111:1087-1095.
16. Larsson J, Andreasson S, Bauer B. Cone b-wave implicit time as an early predictor of rubeosis in central retinal vein occlusion. Am J Ophthalmol 1998; 125:247-249.
17. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997; 115:486-491.
18. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. 1981. Retina 2005; (5 SUPPL):27-55
19. Abu El-Asrar AM, Abdel Gader AG, Al-Amro S, Al-Momen AK. Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998; 95:133-143. (Pubitemid 29335368)
20. Browning DJ, Scott AQ, Peterson CB, et al. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 1998; 105:776-784. (Pubitemid 28225480)
21. Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of nonischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989; 73:895-899. (Pubitemid 20004003)
22. Wolf S, Arend O, Bertram B, et al. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 1994; 232:33-39. (Pubitemid 24060668)
23. Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117:1124.e1-1133.e1.
24. Kinge B, Stordahl PB, Forsaa V, et al. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. Am J Ophthalmol 2010; 150:310-314.
25. Ip MS, Scott IU, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009; 127:1101-1114.
26. Jonas JB, Akkoyun I, Kamppeter B, et al. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion. Eur J Ophthalmol 2005; 15:751-758. (Pubitemid 43074702)
27. Haller JA, Bandello F, Belfort R Jr, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117:1134e3-1146e3.
28. McAllister IL, Gillies ME, Smithies LA, et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology 2010; 117:954-965.
29. McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998; 126:219-229. (Pubitemid 28397095)
30. Fekrat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 1998; 116:43-52. (Pubitemid 28098893)
31. Aktan SG, Subasi M, Akbatur H, Or M. Problems of chorioretinal venous anastomosis by laser for treatment of nonischemic central retinal vein occlusion. Ophthalmologica 1998; 212:389-393. (Pubitemid 28446595)
32. Browning DJ, Rotberg MH. Vitreous hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol 1996; 122:588-589. (Pubitemid 26329701)
33. Vasco-Posada J. Modification of the circulation in the posterior pole of the eye. Ann Ophthalmol 1972; 4:48-59.
34. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001; 21:408-415. (Pubitemid 32971349)
35. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE. Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 2006; 26:297-305. (Pubitemid 44318183)
36. Callizo J, Kroll P, Mennel S, et al. Radial optic neurotomy for central retinal vein occlusion: long-term retinal perfusion outcome. Ophthalmologica 2009; 223:313-319.
37. Skevas C, Wagenfeld L, Feucht M, et al. Radial optic neurotomy in central retinal vein occlusion does not influence ocular hemodynamics. Ophthalmologica 2011; 225:41-46.
38. Park DH, Kim IT. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 2010; 30:117-124.
39. DeCroos FC, Shuler RK Jr, Stinnett S, Fekrat S. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol 2009; 147:627e1-633e1.
40. Mandelcorn MS, Mandelcorn E, Guan K, Adatia FA. Surgical macular decompression for macular edema in retinal vein occlusion. Can J Ophthalmol 2007; 42:116-122. (Pubitemid 46408905)
41. Yeshaya A, Treister G. Pars plana vitrectomy for vitreous hemorrhage and retinal vein occlusion. Ann Ophthalmol 1983; 15:615-617 (Pubitemid 13076766)